-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on BioNTech, Lowers Price Target to $110

Benzinga·11/04/2026 13:26:29
Listen to the news
Evercore ISI Group analyst Cory Kasimov maintains BioNTech (NASDAQ:BNTX) with a Outperform and lowers the price target from $120 to $110.